https://www.taxtmi.com/news?id=12482 Approval was granted for a voluntary open offer under SEBI (SAST) Regulations by M/s GlaxoSmithKline Pte Limited, Singapore to acquire 24.33% of the equity of its existing Indian subsidiary in the pharmaceutical sector, with executive clearance authorising the foreign acquisition and consequent inward foreign investment. en-us Thu, 20 Feb 2014 11:35:01 +0530 Thu, 20 Feb 2014 11:35:01 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=12482 Approval was granted for a voluntary open offer under SEBI (SAST) Regulations by M/s GlaxoSmithKline Pte Limited, Singapore to acquire 24.33% of the equity of its existing Indian subsidiary in the pharmaceutical sector, with executive clearance authorising the foreign acquisition and consequent inward foreign investment. News - Thu, 20 Feb 2014 11:35:01 +0530 https://www.taxtmi.com/news?id=12482